glp 1 drugs for type 2 diabetes GLP-1 May Lower CV Risk in TAVI Patients With or Obesity GLP-1 Drugs and the Physiology

Lactobacillus rhamnosus CNCM I-3690 and the commensal bacterium Faecalibacterium prausnitzii A2-165 exhibit similar protective effects to induced barrier hyper-permeability in mice

Alikhan, A., Felsten, L

Tirzepatide, a dual GIP/GLP-1 agonist, has demonstrated superior weight loss efficacy, reshaping prescriber preferences in obesity management

In this study, we evaluated the effect of Lca, the mitochondrial FAO activator, on inflammatory cytokines expression, intracellular and mitochondrial reactive oxygen species (ROS) production, and mitochondrial dynamics triggered by LPS in THP-1 derived macrophages

How long does it take for glutathione to improve sleep